counter-ion raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-06-16. Anything still debated is marked as such rather than presented as settled.
Published research has focused mainly on neurological and cognitive endpoints in animal models, with proposed mechanisms involving brain-derived neurotrophic factor and related signalling pathways. A substantial share of the human data originates from a limited number of research groups, and independent replication in other countries remains sparse. Regulatory status reflects that distribution: the peptide is registered as a medicine in Russia and appears in some neighbouring markets, while elsewhere it is handled as a research chemical without approved therapeutic labelling. Questions about dose-response relationships, long-term effects, and comparability across studies are still open.
Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.
Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
Lyophilized material is chemically stable for extended periods when kept dry, cold, and protected from light. The powder is hygroscopic, so vials should be warmed to room temperature before opening to reduce condensation on the contents. Once dissolved, the peptide is far less stable because peptide bonds are susceptible to hydrolysis and the methionine residue can oxidize. Solutions are typically aliquoted and held at 2-8 °C for short intervals or frozen for longer ones, and repeated freeze-thaw cycles should be avoided.
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
| Property | Value | Notes |
|---|---|---|
| Purity assay | RP-HPLC, UV 214 nm | Typical research grade 95 percent or higher |
| Mass confirmation | ESI-MS or MALDI-TOF | Compared with theoretical value |
| Main degradation route | Methionine oxidation | Sulfoxide formation in solution |
| Powder storage | -20 °C, desiccated | Amber vial, minimal headspace |
| Working solution | Sterile water or saline | Prepare fresh; avoid repeated thawing |
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, with ultraviolet detection near 214 nanometers for the peptide backbone. Mass spectrometry, either electrospray or matrix-assisted laser desorption, confirms molecular mass and detects truncation or modification products. Amino acid analysis can verify composition. Because the sequence contains no strongly absorbing aromatic residue apart from phenylalanine, detection wavelengths are chosen carefully. Purity values above 95 percent are typical for research-grade material.
=== Tokusou Combinations === Dekaranger Robo (デカレンジャーロボ, Dekarenjā Robo): The Dekarangers' first giant robot composed of the five main Deka Machines that wields the Signal Cannon, which allows it to perform the Justice Flasher (ジャスティスフラッシャー, Jasutisu Furasshā) finisher, and the Judgement Sword, which allows it to perform the Judgement Crash (ジャッジメントクラッシュ, Jajjimento Kurasshu) finisher. Super Dekaranger Robo (スーパーデカレンジャーロボ, Gattai Sūpā Dekarenjā Robo): The Super Tokusou Combination (超特捜合体, Chō Tokusō Gattai) of Dekaranger Robo and the Deka Bike that is equipped with a series of boosters. Its finishers are the Gatling Punch (ガトリングパンチ, Gatoringu Panchi) and the Dynamite Upper (ダイナマイトアッパー, Dainamaito Appā). Dekaranger Robo Full Blast Custom (デカレンジャーロボ フルブラストカスタム, Dekarenjā Robo Furu Burasuto Kasutamu): A combination of Dekaranger Robo and the Blast Buggy that wields the Blast Launcher (ブラストランチャー, Burasuto Ranchā) and the Blast Shield (ブラストシールド, Burasuto Shīrudo), which allows it to perform the Spinning Blast (スピニングブラスト, Supiningu Burasuto) attack. The Blast Launcher and Shield can also combine to form the Full Blast Launcher (フルブラストランチャー, Furu Burasuto Ranchā), which allows Dekaranger Robo to perform the Full Blast (フルブラスト, Furu Burasuto) finisher. This formation appears exclusively in the film Tokusou Sentai Dekaranger The Movie: Full Blast Action.
In January 2026, Thomas Crosbie, an American military expert working at the Royal Danish Defence College, said that any attempt to seize Greenland would constitute a criminal act, and that Denmark, with the backing of its allies, would have the legal right to arrest any Americans involved in such actions and prosecute them under Danish criminal law. Danish troops in Greenland are legally obligated to defend Danish territory under military law. Under a 1952 standing order, Danish troops are ordered to "immediately take up the fight without waiting for, or seeking orders" in "the event of an attack on Danish territory". The Danish government confirmed in January 2026 that the order remains in place and that Danish soldiers would shoot back if Greenland is attacked. The Ministry of Defence said Danish troops would immediately respond to an invasion of Greenland with force and the chairman of the Defence Committee, Rasmus Jarlov, said Denmark would invoke Article 5 if attacked by the US. Jarlov said an American attack would mean war with Denmark and that retaliation would include deadly force. As of January 2026, Article 5 has been invoked only once in NATO history: in response to the September 11 attacks on the US in 2001, when Denmark volunteered "to fight alongside American soldiers in two different conflicts ... [deploying] tens of thousands of troops to Afghanistan and Iraq over two decades ... [suffering] the third-highest per capita casualty rate".
Measurement tools, such as goniometers and inclinometers, aid in standardized quantification of joint motion relative to normative values or ranges. Tests that follow functional movements, such as reaching overhead, squatting, or rotating the neck, are used to evaluate whether reduced ROM translates into activity limitation. When hypomobility is regional, clinicians can use condition-specific values to compare the patient's ROM values against. For instance, in the shoulder, adhesive capsulitis (frozen shoulder) is defined by marked loss of both active and passive motion (particularly external rotation and abduction). For the knee, postoperative arthrofibrosis is typically diagnosed when extension loss exceeds 10° or flexion is limited to less than 100°, with more severe forms showing a flexion deficit of 25° or greater. In the spine, decreased ROM is assessed using values developed for ankylosing spondylitis and related disorders. The Modified Schober Test measures lumbar flexion. An increase of less than 5 cm indicates limited motion, chest expansion of 2.5 cm or less suggests thoracic restriction, and an occiput-to-wall distance greater than 2 cm shows thoracic or cervical extension limitation. The Bath Ankylosing Spondylitis Metrology Index (BASMI) provides a composite score summarizing these spinal mobility measures and is widely used to quantify skeletal hypomobility.
Individuals with this disorder typically experience progressive muscle weakness of the leg and pelvis muscles, which is associated with a loss of muscle mass (wasting). Muscle weakness also occurs in the arms, neck, and other areas, but is not as noticeably severe as in the lower half of the body. Calf muscles initially enlarge during the ages of 5–15 (an attempt by the body to compensate for the loss of muscle strength), but the enlarged muscle tissue is eventually replaced by fat and connective tissue (pseudohypertrophy) as the legs become less used (with use of a wheelchair).
== Treatment == There is no antidote for strychnine poisoning. Strychnine poisoning demands aggressive management with early control of muscle spasms, intubation for loss of airway control, toxin removal (decontamination), intravenous hydration and potentially active cooling efforts in the context of hyperthermia as well as hemodialysis in kidney failure (strychnine has not been shown to be removed by hemodialysis). Treatment involves oral administration of activated charcoal, which adsorbs strychnine within the digestive tract; unabsorbed strychnine is removed from the stomach by gastric lavage, along with tannic acid or potassium permanganate solutions to oxidize strychnine.
Sources: en.wikipedia.org
=== Genetic testing === For some types of paediatric ILDs and few forms adult ILDs, genetic causes have been identified. These may be identified by blood tests. For a limited number of cases, this is a definite advantage, as a precise molecular diagnosis can be done; frequently then there is no need for a lung biopsy. Testing is available for
== Further reading == Oliver, Brian; Devitt, Catherine; Park, Grace; Razak, Alina; Liu, Sun Mei; Bergese, Sergio D. (2025). "Drugs in Development to Manage Acute Pain". Drugs. 85 (1): 11–19. doi:10.1007/s40265-024-02118-0. PMID 39560856. Broadfoot, Marla (20 August 2024). "New Painkiller Could Bring Relief to Millions—Without Addiction Risk". Scientific American. Archived from the original on 30 December 2024. Retrieved 20 July 2026.
The library in 1885 consisted of approximately 400,000 works, including about 2,400 incunabula, approximately 250 Aldines, and 2,840 manuscripts. These volumes came from the libraries of the former universities of Frankfurt and Breslau and from disestablished monasteries, and also included the oriental collections of the Bibliotheca Habichtiana and the academic Leseinstitut. In addition, the university owned an observatory; a five-hectare botanical garden; a botanical museum and a zoological garden founded in 1862 by a joint-stock company; a natural history museum; zoological, chemical, and physical collections; the chemical laboratory; the physiological plant; a mineralogical institute; an anatomical institute; clinical laboratories; a gallery (mostly from churches, monasteries, etc.) full of old German works; the museum of Silesian antiquities; and the state archives of Silesia.
Dimerization and oligomerization processes have been observed and attributed to several molecular mechanisms, including intermolecular disulfide formation, bridging through metals bound by either Cys or His residues on different MTs, or inorganic phosphate-mediated interactions. Dimeric and polymeric MTs have been shown to acquire novel properties upon metal detoxification, but the physiological significance of these processes has been demonstrated only in the case of prokaryotic Synechococcus SmtA. The MT dimer produced by this organism forms structures similar to zinc fingers and has Zn-regulatory activity. Metallothioneins have diverse metal-binding preferences, which have been associated with functional specificity. As an example, the mouse MT1 preferentially binds divalent metal ions (Zn(II), Cd(II),...), while yeast CUP1 is selective for monovalent metal ions (Cu(I), Ag(I),...). Strictly metal-selective MTs with metal-specific physiological functions were discovered by Dallinger et al. (1997) in pulmonate snails (Gastropoda, Mollusca). The Roman snail (Helix pomatia), for example, possesses a Cd-selective (CdMT) and a Cu-selective isoform (CuMT) involved in Cd detoxification and Cu regulation, respectively. While both isoforms contain unvaried numbers and positions of Cys residues responsible for metal ligation, metal selectivity is apparently achieved by sequence modulation of amino acid residues not directly involved in metal binding (Palacios et al. 2011).
The country was mostly savannah, although the moist and mountainous eastern highlands supported areas of tropical evergreen and hardwood forests. Trees found in these Eastern Highlands included teak, mahogany, enormous specimens of strangling fig, forest newtonia, big leaf, white stinkwood, chirinda stinkwood, knobthorn and many others. In the low-lying parts of the country, fever trees, mopane, combretum and baobabs abound. Much of the country was covered by miombo woodland, dominated by brachystegia species and others. Among the numerous flowers and shrubs were hibiscus, flame lily, snake lily, spider lily, leonotus, cassia, tree wisteria and dombeya. There were around 350 species of mammals that can be found in Rhodesia. There were also many snakes and lizards, over 500 bird species, and 131 fish species.
Sources: en.wikipedia.org
Reversed-phase HPLC gives the main purity figure, most often with UV detection near 214 nanometres. Mass spectrometry then confirms the molecular mass. Together the two methods distinguish a correct sequence from a closely related impurity.
The main chemical risks are methionine oxidation and backbone hydrolysis in solution. Moisture and repeated temperature cycling accelerate both processes. Dry powder held cold and desiccated is considerably more stable than any reconstituted preparation.
It holds a medicine registration in Russia, where it has been used clinically for decades. In most other countries it is treated as a research chemical. That split explains the uneven distribution of clinical literature.
Dry powder is normally held at -20 °C or lower, away from light and moisture. Sealed vials can also be kept at 2-8 °C for shorter intervals. Warming to room temperature before opening prevents condensation.